共 13 条
- [1] CYCLOSPORINE (CSA) ELIMINATES THE INCREASED RISK IN HIGH-RISK RENAL-TRANSPLANT RECIPIENTS (RTR) [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1089 - 1089
- [3] Enhanced ATP secretion in platelets from tacrolimus (TACRO) and cyclosporine (CSA)-treated renal transplant recipients (RTR's) [J]. FASEB JOURNAL, 2000, 14 (04): : A187 - A187
- [4] No differences in plasma homocysteine (Hcy) levels between cyclosporine (CsA)- or tacrolimus (TAC)- treated renal transplant recipients (RTR) [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 372A - 372A
- [5] DO EARLY CYCLOSPORINE (CSA) LEVELS AFFECT INCIDENCE OF ACUTE REJECTION IN RENAL-TRANSPLANT RECIPIENTS [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1096 - 1096
- [8] ABBREVIATED PHARMACOKINETIC (PK) PROFILES IN AREA-UNDER-THE-CURVE (AUC) MONITORING OF CYCLOSPORINE (CSA) THERAPY IN DE-NOVO RENAL-TRANSPLANT PATIENTS [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1103 - 1103